Our Business Development team are recognised for their experience in intellectual property management and commercialisation.
With our researchers and their discoveries, the team have a strong pipeline of translatable biomedical discoveries. The focus is on the translation of research to deliver health benefits to the community, increasingly this requires commercial partnerships to progress discoveries through to the marketplace. Below are some of our research and technology areas of expertise. Contact us if you are interested in these, or if you have specific area you would like to pursue.
Central Nervous System
SRY inhibition to treat Parkinson’s Disease in males
Treatment for White Matter Impairment in Newborns
Gene Therapy
RNA interference with Potent Immune System Activation
SRY inhibition to treat Parkinson’s Disease in males
Infectious Diseases
TLR7/8 Antagonists: Anti-bacterial and Anti-inflammatory Agents
Inflammation
Exosome Therapy – a cell-free approach to regenerative medicine
RNA interference with Potent Immune System Activation
TLR7/8 Antagonists: Anti-bacterial and Anti-inflammatory Agents
Oncology
Small molecule inhibitors of liver Receptor Homolgo-1 (LRH-1)
Paediatrics
Treatment for White Matter Impairment in Newborns
Reproductive Health
Treating pelvic organ prolapse. A tissue engineering approach using novel designed scaffolds embedded with autologous endometrial mesenchymal stem cells.
Regenerative Medicine
Exosome Therapy – a cell-free approach to regenerative medicine
Women’s Health
Treating pelvic organ prolapse. A tissue engineering approach using novel designed scaffolds embedded with autologous endometrial mesenchymal stem cells.